Literature DB >> 33633560

Evolution of Apathy in Early Parkinson's Disease: A 4-Years Prospective Cohort Study.

Ruwei Ou1, Junyu Lin1, Kuncheng Liu1, Zheng Jiang1, Qianqian Wei1, Yanbing Hou1, Lingyu Zhang1, Bei Cao1, Bi Zhao1, Wei Song1, Huifang Shang1.   

Abstract

Objective: We investigated the prevalence, evolution, associated factors, and risk factors of apathy in a cohort of patients with early-stage Parkinson's disease (PD), who underwent a 4-years prospective follow-up.
Methods: This study included 188 patients with PD (baseline disease duration <3 years) who underwent an annual evaluation using the Lille Apathy Rating Scale (LARS). Based on the cut-off value of -21 observed on the LARS, patients were categorized as PD with and without apathy. The generalized estimating equations (GEE) model was utilized to determine the factors associated with apathy, and the Cox proportional-hazards regression model was used to determine the predictors of apathy.
Results: Apathy increased from a baseline rate of 18.6-28.8% after 4 years; notably, this rate was not persistent across patients' visits. The LARS score was independently associated with the male sex (B 8.131, p = 0.009), low Frontal Assessment Battery (FAB) scores (B 0.567, p = 0.011), low attention scores on the Montreal Cognitive Assessment (MOCA) test (B 0.217, p = 0.026), high Hamilton Depression Rating Scale (HDRS) scores (B 1.362, p < 0.001), high Unified Parkinson's Disease Rating Scale (UPDRS) part III scores (B 1.147, p < 0.001), and prolonged follow-up time (B 1.785, p = 0.048). A high HDRS score was the only predictor of apathy in PD [hazard ratio (HR) 1.043, p = 0.026]. Conclusions: The risk of apathy is higher in men with progressive PD accompanied by disease-specific motor and non-motor symptoms. Depression during early-stage PD is a primary risk factor for apathy in PD.
Copyright © 2021 Ou, Lin, Liu, Jiang, Wei, Hou, Zhang, Cao, Zhao, Song and Shang.

Entities:  

Keywords:  Parkinson's disease; apathy; cohort study; depression; executive function

Year:  2021        PMID: 33633560      PMCID: PMC7901914          DOI: 10.3389/fnagi.2020.620762

Source DB:  PubMed          Journal:  Front Aging Neurosci        ISSN: 1663-4365            Impact factor:   5.750


  35 in total

1.  Mood and motor trajectories in Parkinson's disease: multivariate latent growth curve modeling.

Authors:  Laura B Zahodne; Michael Marsiske; Michael S Okun; Ramon L Rodriguez; Irene Malaty; Dawn Bowers
Journal:  Neuropsychology       Date:  2011-12-05       Impact factor: 3.295

Review 2.  Imaging correlates of apathy and depression in Parkinson's disease.

Authors:  Michel Benoit; Philippe H Robert
Journal:  J Neurol Sci       Date:  2011-08-09       Impact factor: 3.181

3.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

4.  Comparison of the standard and structured interview guide for the Hamilton Depression Rating Scale in depressed geriatric inpatients.

Authors:  P J Moberg; L W Lazarus; R I Mesholam; W Bilker; I L Chuy; I Neyman; V Markvart
Journal:  Am J Geriatr Psychiatry       Date:  2001       Impact factor: 4.105

5.  Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.

Authors:  Stéphane Thobois; Eugénie Lhommée; Hélène Klinger; Claire Ardouin; Emmanuelle Schmitt; Amélie Bichon; Andrea Kistner; Anna Castrioto; Jing Xie; Valerie Fraix; Pierre Pelissier; Stephan Chabardes; Patrick Mertens; Jean-Louis Quesada; Jean-Luc Bosson; Pierre Pollak; Emmanuel Broussolle; Paul Krack
Journal:  Brain       Date:  2013-03-29       Impact factor: 13.501

6.  Apathy in drug-naïve patients with Parkinson's disease.

Authors:  Hui Liu; Ruwei Ou; Qianqian Wei; Yanbing Hou; Lingyu Zhang; Bei Cao; Bi Zhao; Wei Song; Huifang Shang
Journal:  Parkinsonism Relat Disord       Date:  2017-08-10       Impact factor: 4.891

7.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

8.  Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.

Authors:  Kenn Freddy Pedersen; Guido Alves; Kolbjørn Brønnick; Dag Aarsland; Ole-Bjørn Tysnes; Jan Petter Larsen
Journal:  J Neurol       Date:  2009-08-25       Impact factor: 4.849

9.  Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study.

Authors:  K F Pedersen; G Alves; D Aarsland; J P Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-11       Impact factor: 10.154

Review 10.  Apathy: a neuropsychiatric syndrome.

Authors:  R S Marin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1991       Impact factor: 2.198

View more
  4 in total

1.  Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation Analyses.

Authors:  Sarah M Szymkowicz; Jacob D Jones; Holly Timblin; Cameron A Ryczek; Warren D Taylor; Pamela E May
Journal:  Am J Geriatr Psychiatry       Date:  2021-11-21       Impact factor: 7.996

Review 2.  The neuropsychiatry of Parkinson's disease: advances and challenges.

Authors:  Daniel Weintraub; Dag Aarsland; Kallol Ray Chaudhuri; Roseanne D Dobkin; Albert Fg Leentjens; Mayela Rodriguez-Violante; Anette Schrag
Journal:  Lancet Neurol       Date:  2022-01       Impact factor: 44.182

Review 3.  Apathy in Parkinson's Disease: Defining the Park Apathy Subtype.

Authors:  Ségolène De Waele; Patrick Cras; David Crosiers
Journal:  Brain Sci       Date:  2022-07-14

4.  Non-pharmacological intervention effects on apathy caused by central nervous system organic diseases: A network meta-analysis.

Authors:  Shaoying Tan; Xiaoli Lin; Zan Liu; Yao Wu; Bijiao Xie; Tao Wang
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.